new jobs created
female employees, 44% female leaders
tests conducted with Roche products from Jan 2020 to Jun 2021
pesos donated to healthcare causes
Recent years have seen the Philippines make significant strides toward implementing universal health coverage, signing universal healthcare into law, and dedicating more resources to strengthening the country’s health care system.
The national health budget, which has increased an average of 9% the past five years, was 176 billion pesos in 2020, the bulk of which went to the Philippine Health Insurance Corporation, which received 40%, or 71 billion pesos.
Our solutions were used in community surveillance studies and seroprevalence initiatives by the Department of Health, the Philippine Council for Health Research and Development, the Department of Science and Technology, and the Philippine Hospital Infection Control Society to aid the nation in researching and responding to infectious outbreaks.
Expanding testing capacity to aid the Philippines in Combating COVID-19
Roche Diagnostics and Roche Pharmaceuticals Philippines worked in tandem to obtain and supply COVID-19 tests to meet national demand, becoming the nation’s first credible diagnostics company to launch COVID-19 tests in March 2020, further expanding the Philippines’ testing capacity.
Accurate, timely testing of Cardiac Disease with “Beat Matters”
To reach better outcomes for patients with cardiology-related diseases, we launched the “Beat Matters” campaign to drive awareness on diagnostic solutions and the value of accurate and timely testing for cardiac patients.
As of June 2021, 53,670 patients have been diagnosed with our cardiac testing solutions, enabling us to expand our reach to 105,875 patients by end 2021, a 15% increase from 2020.